Skip to main content

Table 1 Preintervention and postintervention study characteristics

From: Streamlining and cycle time reduction of the startup phase of clinical trials

Study characteristicsPreintervention (n = 8)
n (%)
Postintervention (n = 5)
n (%)
Health field
 Cardiac and pulmonary5 (62.5)3 (60.0)
 Cancer and hematology3 (37.5)2 (40.0)
Patient population
 Adult6 (75.0)4 (80.0)
 Pediatric2 (25.0)1 (20.0)
Industry-sponsored study8 (100)5 (100)
Study intervention
 Drug8 (100)5 (100)
Phase
 III5 (62.5)3 (60.0)
 IV3 (37.5)2 (40.0)
International studies/multicenter studies8 (100)5 (100)